Skip to main content

Table 5 Serum concentrations of FBS, Insulin, HbA1c, MDA, TAC and measurements of HOMA-IR, HOMA-β in the curcumin treated and control group

From: The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial

Parameters

Time

Curcumin group (sd ± mean)

Control group (sd ± mean)

P2

FBS (mg/dl)

Baseline

160 ± 35

144 ± 40.6

0.28

Week 10

153 ± 33

147 ± 40.4

0.67

P1

0.05

0.3

 

Mean changes

− 7 ± 2

3 ± 0.2

0.02

Insulin (mU/L)

Baseline

9.2 ± 9

8.3 ± 6

0.70

Week 10

9.4 ± 6

9.7 ± 4.7

0.88

P1

0.9

0.3

 

Mean changes

0.2 ± 3

1.4 ± 1.3

0.65

HbA1c (%)

Baseline

11.3 ± 1.6

11.2 ± 1.3

0.84

Week 10

11 ± 2

11.1 ± 1.8

0.82

P1

0.3

0.3

 

Mean changes

− 0.3 ± 0.4

0.1 ± 0.5

0.65

HOMA-IR

Baseline

62 ± 63

53 ± 40

0.58

Week 10

62.4 ± 42

65 ± 44

0.82

P1

0.9

0.1

 

Mean changes

0.4 ± 21

12 ± 4

0.50

HOMA-B

Baseline

131 ± 119

128 ± 103

0.94

Week 10

134 ± 98

140 ± 66

0.80

P1

0.5

0.09

 

Mean changes

3 ± 21

12 ± 37

0.81

MDA (µmol/L)

Baseline

7.5 ± 1.6

7.5 ± 1.6

0.92

Week 10

8 ± 1.7

8 ± 1.7

0.51

P1

0.2

0.1

 

Mean changes

0.5 ± 0.1

0.5 ± 0.1

0.53

TAC (U/mL)

Baseline

0.81 ± 0.11

0.7 ± 0.1

0.58

Week 10

0.8 ± 0.1

0.8 ± 0.1

0.70

P1

0.2

0.4

 

Mean changes

− 0.01 ± 0.01

0.1 ± 0

0.07

  1. P1: obtained from paired t-test P (p: 0.05)
  2. P2: obtained from Independent sample t-test (p: 0.05)